BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7462397)

  • 1. 6 beta-Hydroxycortisol: a noninvasive indicator of enzyme induction.
    Saenger P; Forster E; Kream J
    J Clin Endocrinol Metab; 1981 Mar; 52(3):381-4. PubMed ID: 7462397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction.
    Saenger P
    Clin Pharmacol Ther; 1983 Dec; 34(6):818-21. PubMed ID: 6641098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.
    Konishi H; Tanaka K; Minouchi T; Yamaji A
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):335-7. PubMed ID: 15298747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism].
    Zhiri A; Wellman-Bednawska M; Siest G
    Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed excretion of 6 beta-hydroxycortisol in lead-toxic children.
    Saenger P; Markowitz ME; Rosen JF
    J Clin Endocrinol Metab; 1984 Feb; 58(2):363-7. PubMed ID: 6420437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.
    Heinemeyer G; Roots I; Lestau P; Klaiber HR; Dennhardt R
    Br J Clin Pharmacol; 1986 Jan; 21(1):9-18. PubMed ID: 2868749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
    Galteau MM; Shamsa F
    Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6 beta-Hydroxycortisol excretion in hypercortisolemic states.
    Voccia E; Saenger P; Peterson RE; Rauh W; Gottesdiener K; Levine LS; New MI
    J Clin Endocrinol Metab; 1979 Mar; 48(3):467-71. PubMed ID: 218996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).
    Challiner MR; Park BK; Odum J; Orton TC; Parker GL
    Biochem Pharmacol; 1980 Dec; 29(24):3319-24. PubMed ID: 6971098
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases.
    Ng MC; Young RP; Critchley JA; Leung NW; Lau JW; Li AK
    Cancer; 1996 Apr; 77(8):1427-33. PubMed ID: 8608525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme induction by enflurane in man.
    Berman ML; Green OC; Calverley RK; Smith NT; Eger EI
    Anesthesiology; 1976 Jun; 44(6):496-500. PubMed ID: 1275317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction.
    Ohkita C; Goto M
    DICP; 1990 Sep; 24(9):814-6. PubMed ID: 2260334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.
    Bienvenu T; Rey E; Pons G; d'Athis P; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):441-5. PubMed ID: 1800391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy.
    Zhiri A; Wellman-Bednawska M; Siest G
    Clin Chim Acta; 1986 Jun; 157(3):267-76. PubMed ID: 3731488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous high-performance liquid chromatographic determination of 6 beta-hydroxycortisol and cortisol in urine with fluorescence detection and its application for estimating hepatic drug-metabolizing enzyme induction.
    Inoue S; Inokuma M; Harada T; Shibutani Y; Yoshitake T; Charles B; Ishida J; Yamaguchi M
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):15-23. PubMed ID: 7866543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
    Rost KL; Mansmann U; Roots I
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in urinary levels of free 6 beta-hydroxycortisol, cortisol, and estrogens in late pregnancy.
    Hunter DJ; Keane P; Walker WH; YoungLai EV
    Gynecol Obstet Invest; 1984; 18(2):83-7. PubMed ID: 6541177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
    Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
    Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol production rate and the urinary excretion of 17-hydroxycorticosteroids, free cortisol, and 6 beta-hydroxycortisol in healthy elderly men and women.
    Barton RN; Horan MA; Weijers JW; Sakkee AN; Roberts NA; van Bezooijen CF
    J Gerontol; 1993 Sep; 48(5):M213-8. PubMed ID: 8366263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.